HDFC Pharma and Healthcare Fund Direct Growth is an equity new fund offer (NFO) launched by HDFC Asset Management Co Ltd. The investors can apply to the NFO from 14 September 2023 to 28 September 2023. As per the SEBI defined riskometer, the HDFC Pharma and Healthcare Fund Direct Growth is rated Very High Risk. HDFC Pharma and Healthcare Fund Direct Growth has defined its benchmark as Nifty 500.
₹ 10 | |
14 September 2023 | |
28 September 2023 | |
05 October 2023 | |
Exit Load | 1% |
Benchmark | S&P BSE Healthcare TR INR |